Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9,344 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A Prospective Cohort Study to Assess Obstructive Respiratory Disease Phenotypes and Endotypes in Japan: The TRAIT Study Design.
Hizawa N, Fukunaga K, Sugiura H, Nakano Y, Kato M, Sugiyama Y, Hanazawa T, Kaise T, Tal-Singer R, Jones PW, Barnes N, Compton C, Ishii T. Hizawa N, et al. Among authors: kato m. Int J Chron Obstruct Pulmon Dis. 2021 Jun 18;16:1813-1822. doi: 10.2147/COPD.S308327. eCollection 2021. Int J Chron Obstruct Pulmon Dis. 2021. PMID: 34168442 Free PMC article.
A randomized trial of symptom-based management in Japanese patients with COPD.
Betsuyaku T, Kato M, Fujimoto K, Kobayashi A, Hayamizu T, Hitosugi H, Hagan G, James MH, Jones PW. Betsuyaku T, et al. Among authors: kato m. Int J Chron Obstruct Pulmon Dis. 2018 Aug 13;13:2409-2423. doi: 10.2147/COPD.S152723. eCollection 2018. Int J Chron Obstruct Pulmon Dis. 2018. PMID: 30147307 Free PMC article. Clinical Trial.
The IMPACT Study - Single Inhaler Triple Therapy (FF/UMEC/VI) Versus FF/VI And UMEC/VI In Patients With COPD: Efficacy And Safety In A Japanese Population.
Kato M, Tomii K, Hashimoto K, Nezu Y, Ishii T, Jones CE, Kilbride S, Gross AS, Clifton CS, Lipson DA. Kato M, et al. Int J Chron Obstruct Pulmon Dis. 2019 Dec 6;14:2849-2861. doi: 10.2147/COPD.S226601. eCollection 2019. Int J Chron Obstruct Pulmon Dis. 2019. PMID: 31839705 Free PMC article. Clinical Trial.
Triple Versus Dual Combination Therapy in Chronic Obstructive Pulmonary Disease in Asian Countries: Analysis of the IMPACT Trial.
Halpin DMG, Criner GJ, Dransfield MT, Han MK, Hartley B, Harvey C, Jones CE, Kato M, Lange P, Lettis S, Lomas DA, Martinez FJ, Martin N, Singh D, Wise R, Zheng J, Lipson DA. Halpin DMG, et al. Among authors: kato m. Pulm Ther. 2021 Jun;7(1):101-118. doi: 10.1007/s41030-020-00136-3. Epub 2020 Nov 17. Pulm Ther. 2021. PMID: 33201438 Free PMC article.
Treatable traits in the NOVELTY study.
Agustí A, Rapsomaniki E, Beasley R, Hughes R, Müllerová H, Papi A, Pavord ID, van den Berge M, Faner R; NOVELTY Study Investigators. Agustí A, et al. Respirology. 2022 Nov;27(11):929-940. doi: 10.1111/resp.14325. Epub 2022 Jul 21. Respirology. 2022. PMID: 35861464 Free PMC article.
9,344 results